124 related articles for article (PubMed ID: 23782452)
1. Evidence of enhanced systemic inflammation in stable kidney transplant recipients with low Framingham risk scores.
Mansell H; Rosaasen N; Dean J; Shoker A
Clin Transplant; 2013; 27(4):E391-9. PubMed ID: 23782452
[TBL] [Abstract][Full Text] [Related]
2. Contribution of impaired renal function to cardiovascular risk prediction models in renal transplant recipients.
Benguzzi M; Mansell H; Hassan A; Elmoselhi H; Mainra R; Shoker A
Clin Transplant; 2014 Dec; 28(12):1383-92. PubMed ID: 25251543
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of the Framingham cardiovascular risk scores in a liver transplant population.
Mansell H; Worobetz LJ; Sylwestrowicz T; Shoker AS
Transplant Proc; 2013; 45(1):308-14. PubMed ID: 23267816
[TBL] [Abstract][Full Text] [Related]
4. Normal adiponectin levels in kidney transplant patients with hypertension.
Leibowitz A; Peleg E; Ben-David A; Sharabi Y; Kamari Y; Holzman E; Grossman E
Clin Transplant; 2013; 27(4):562-6. PubMed ID: 23758483
[TBL] [Abstract][Full Text] [Related]
5. High-sensitivity troponin T levels in kidney transplant recipients.
Arroyo D; Quiroga B; Panizo N; Rodríguez-Ferrero M; Macías N; Reque J; Anaya F; Luño J
Transplant Proc; 2012 Nov; 44(9):2545-7. PubMed ID: 23146449
[TBL] [Abstract][Full Text] [Related]
6. Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients.
Silver SA; Huang M; Nash MM; Prasad GV
Transplantation; 2011 Jul; 92(2):183-9. PubMed ID: 21558986
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid hormone and clinical outcome in kidney transplant patients with optimal transplant function.
Bleskestad IH; Bergrem H; Leivestad T; Hartmann A; Gøransson LG
Clin Transplant; 2014 Apr; 28(4):479-86. PubMed ID: 25649861
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of all-cause mortality and renal graft loss in stable renal transplant recipients with hyperparathyroidism.
Pihlstrøm H; Dahle DO; Mjøen G; Pilz S; März W; Abedini S; Holme I; Fellström B; Jardine AG; Holdaas H
Transplantation; 2015 Feb; 99(2):351-9. PubMed ID: 25594550
[TBL] [Abstract][Full Text] [Related]
9. Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.
Lin WX; Christiansen D; Fu LL; Roberts MA; Sandrin MS; Ierino FL
Nephrology (Carlton); 2012 May; 17(4):415-22. PubMed ID: 22308996
[TBL] [Abstract][Full Text] [Related]
10. Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery disease.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Transplant Proc; 2006 Nov; 38(9):2895-8. PubMed ID: 17112858
[TBL] [Abstract][Full Text] [Related]
11. Arterial stiffness and wave reflections in renal transplant recipients.
Verbeke F; Van Biesen W; Peeters P; Van Bortel LM; Vanholder RC
Nephrol Dial Transplant; 2007 Oct; 22(10):3021-7. PubMed ID: 17597092
[TBL] [Abstract][Full Text] [Related]
12. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.
Chitalia N; Raja RB; Bhandara T; Agrawal P; Kaski JC; Jha V; Banerjee D
J Nephrol; 2010; 23(1):77-84. PubMed ID: 20091490
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with increased arterial stiffness in renal transplant recipients.
Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
Med Sci Monit; 2010 Jun; 16(6):CR301-6. PubMed ID: 20512094
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.
Soveri I; Abedini S; Holdaas H; Jardine A; Eriksson N; Fellström B
Clin Transplant; 2009; 23(6):914-20. PubMed ID: 19594771
[TBL] [Abstract][Full Text] [Related]
16. Increased cardiac troponin T levels are related to inflammatory markers and various indices of renal function in chronic renal disease patients.
Sezer S; Karakan S; Ozdemir N
Ren Fail; 2012; 34(4):454-9. PubMed ID: 22320145
[TBL] [Abstract][Full Text] [Related]
17. Circulating markers of endothelial dysfunction interact with proteinuria in predicting mortality in renal transplant recipients.
van Ree RM; Oterdoom LH; de Vries AP; Homan van der Heide JJ; van Son WJ; Navis G; Gans RO; Bakker SJ
Transplantation; 2008 Dec; 86(12):1713-9. PubMed ID: 19104410
[TBL] [Abstract][Full Text] [Related]
18. Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.
Di Maira T; Rubin A; Puchades L; Aguilera V; Vinaixa C; Garcia M; De Maria N; Villa E; Lopez-Andujar R; San Juan F; Montalva E; Perez J; Prieto M; Berenguer M
Liver Transpl; 2015 Jun; 21(6):812-22. PubMed ID: 27396823
[TBL] [Abstract][Full Text] [Related]
19. The relation between hypomagnesaemia and vascular stiffness in renal transplant recipients.
Van Laecke S; Maréchal C; Verbeke F; Peeters P; Van Biesen W; Devuyst O; Jadoul M; Vanholder R
Nephrol Dial Transplant; 2011 Jul; 26(7):2362-9. PubMed ID: 21212164
[TBL] [Abstract][Full Text] [Related]
20. Elevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.
Mansell H; Soliman M; Elmoselhi H; Shoker A
PLoS One; 2015; 10(11):e0142141. PubMed ID: 26544186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
